Your browser doesn't support javascript.
loading
Prospective trial of minimal residual disease assessment by multiparametric flow cytometry for multiple myeloma in the era of bortezomib-based chemotherapy.
Clark, C Amos; Mosse, Claudio A; Chen, Heidi; Byrne, Michael; Chinratanalab, Wichai; Engelhardt, Brian G; Goodman, Stacey A; Harrell, Shelton L; Kassim, Adetola A; Savani, Bipin N; Sengsayadeth, Salyka; Jagasia, Madan; Cornell, R Frank.
Afiliación
  • Clark CA; Department of Medicine, Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Mosse CA; Department of Hematopathology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Chen H; Division of Biostatistics and Quantitative Sciences, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Byrne M; Department of Medicine, Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Chinratanalab W; Department of Medicine, Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Engelhardt BG; Department of Medicine, Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Goodman SA; Department of Medicine, Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Harrell SL; Department of Medicine, Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Kassim AA; Department of Medicine, Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Savani BN; Department of Medicine, Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Sengsayadeth S; Department of Medicine, Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Jagasia M; Department of Medicine, Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Cornell RF; Department of Medicine, Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, USA. robert.f.cornell@vanderbilt.edu.
Bone Marrow Transplant ; 53(12): 1589-1592, 2018 12.
Article en En | MEDLINE | ID: mdl-29915217
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasia Residual / Citometría de Flujo / Bortezomib / Mieloma Múltiple / Antineoplásicos Tipo de estudio: Observational_studies Límite: Adult / Aged / Humans / Middle aged Idioma: En Revista: Bone Marrow Transplant Asunto de la revista: TRANSPLANTE Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasia Residual / Citometría de Flujo / Bortezomib / Mieloma Múltiple / Antineoplásicos Tipo de estudio: Observational_studies Límite: Adult / Aged / Humans / Middle aged Idioma: En Revista: Bone Marrow Transplant Asunto de la revista: TRANSPLANTE Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos